ReviewWorld journal of emergency surgery : WJES2026
From molecular networks to precision therapeutics: the evolving landscape of trauma-induced coagulopathy.
Review in World journal of emergency surgery : WJES, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTrauma-induced coagulopathy (TIC) affects approximately one quarter of severely injured patients and is linked to markedly increased mortality. Despite improvements in trauma care, understanding of TIC mechanisms and development of targeted treatment strategies remain limited. This review summarizes recent advances in mechanistic studies and translational research that inform targeted approaches for TIC.
methodsA systematic PubMed search identified English-language basic research on TIC published from January 2016 to July 2025. The review focused on studies utilizing established animal models and experimental systems to explore disease mechanisms, intervention strategies, and translational relevance. Included studies were assessed for scientific rigor, clinical significance, and contributions to advancing TIC knowledge.
resultsRecent research clarifies the contributions of endothelial glycocalyx shedding, platelet dysfunction, and imbalanced coagulation and fibrinolysis to TIC development. Inflammatory processes and immunothrombosis further disrupt hemostasis. Animal studies in a variety of species have improved understanding of the roles of tissue injury, shock, biological sex, comorbidities, and environmental influences. Preclinical progress includes innovations in fluid resuscitation, precise blood component therapy, targeted antifibrinolytics, vasoactive medications, and cellular therapies. Novel diagnostic tools featuring viscoelastic assays and new biomarkers offer promise for earlier detection and better classification of TIC subtypes. However, challenges persist related to species-specific responses, optimal timing of interventions, and individualized treatment.
conclusionIntegrating mechanistic and translational research is transforming the concept of TIC into a dynamic, heterogeneous syndrome that requires individualized therapies. Advances in diagnostics and precision interventions will play a critical role in improving global outcomes for trauma patients with TIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.